Provoked Craving Relief Study by NRT
NCT01476202 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2013-09-30
Summary
This study is designed to assess the ability of the mint nicotine mouth strip to relieve provoked cigarette craving in light smokers compared to nicotine lozenge and nicotine gum.
Conditions
- Smoking Cessation
Interventions
- DRUG
-
nicotine
nicotine in the form of a mouth strip, lozenge and gum
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum
NCT01152736 ·Status: COMPLETED ·Phase: NA
-
Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge
NCT01075659 ·Status: COMPLETED ·Phase: PHASE2
-
Medicinal Nicotine for Preventing Cue Induced Craving
NCT02347605 ·Status: COMPLETED ·Phase: NA
-
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
NCT01522963 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of a New Nicotine Replacement Therapy
NCT00764439 ·Status: COMPLETED ·Phase: PHASE2
-
Single-dose Pharmacokinetics of Oral Nicotine Replacement Products
NCT01228617 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation
NCT00985985 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum
NCT01152723 ·Status: COMPLETED ·Phase: NA
-
Smoking Reduction or Cessation With Nicotine Replacement Therapy
NCT00840242 ·Status: COMPLETED ·Phase: PHASE3
-
"EASY EFFECTIVE SMOKELESS" With NICORETTE®
NCT01323491 ·Status: COMPLETED
-
Oral Tolerability Of Two Nicotine Dosage Forms
NCT00682461 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Cessation Preferences of Menthol Smoker
NCT02020005 ·Status: COMPLETED ·Phase: NA
-
Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.
NCT01234792 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers
NCT03259607 ·Status: COMPLETED ·Phase: PHASE1
-
Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product
NCT01084603 ·Status: COMPLETED ·Phase: NA
-
Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
NCT01308736 ·Status: COMPLETED ·Phase: NA
-
Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations
NCT03087786 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers
NCT03543137 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment
NCT00749463 ·Status: COMPLETED ·Phase: PHASE4
-
Varenicline for Light Smokers
NCT01639560 ·Status: COMPLETED ·Phase: PHASE4
-
Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum
NCT01152749 ·Status: COMPLETED ·Phase: NA
-
Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.
NCT01227720 ·Status: COMPLETED ·Phase: NA
-
Comparison of Demand and Substitution for Nicotine Pouches as a Function of Nicotine Dosage
NCT07213947 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® Microtab
NCT01238640 ·Status: COMPLETED ·Phase: NA